FindTrial
Sign In

TO SEE THE EFFICACY OF HOMLOEOPATHY MEDICINE NAME CIMICIFUGA IN CASES OF DYSMENORRHEA

TO STUDY EFFICACY OF CIMICIFUGA IN DYSMENORHHEA - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099149
Enrollment
40
Registered
2025-12-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: CIMICIFUGA: 6C/30C/200C/1M OD/BD/TDS THE POTENCY AND REPITITION OF CIMICIFUGA WILL BE SELECTED DEPENDING UPON THE SUSCEPTIBILITY OF PATIENT Control Intervention1: NIL: NIL

Sponsors

DR PRIYA TALSANIYA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. FEMALE AGED 15 TO 35 YEARS HISTORY OF REGULAR MENSTRUAL CYCLES THAT IS 21 TO 35 DAYS. 2. CLINICAL DIAGNOSIS OF PRIMARY DYSMENORRHEA. 3. MODERATE TO SEVERE MENSTRUAL PAIN ACCPORDING TO VAS SCORE. 4. WILLING TO GIVE INFORMED CONSENT AND COMPLY WITH STUDY PROTOCOL.

Exclusion criteria

Exclusion criteria: 1. KNOWN OR SUSPECTED SECONDARY DYSMENORRHEA. 2. CURRENT USE OF HORMONAL CONTRACEPTIVES, NSAIDS.

Design outcomes

Primary

MeasureTime frame
VISUAL ANALNOG SCALE(VAS)Timepoint: AT BASELINE AND AT THE END OF TRATMENT AS PER REQUIREMENT OF CASE—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDR NANDANI BARVE

BARODA HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL

nandinisk23@gmail.com9998216445

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026